194 related articles for article (PubMed ID: 34089223)
1. Expanding the clinical and radiological phenotypes of leukoencephalopathy due to biallelic HMBS mutations.
Stutterd CA; Kidd A; Florkowski C; Janus E; Fanjul M; Raizis A; Wu TY; Archer J; Leventer RJ; Amor DJ; Lukic V; Bahlo M; Gow P; Lockhart PJ; van der Knaap MS; Delatycki MB
Am J Med Genet A; 2021 Oct; 185(10):2941-2950. PubMed ID: 34089223
[TBL] [Abstract][Full Text] [Related]
2. Acute intermittent porphyria-related leukoencephalopathy.
Kevelam SH; Neeleman RA; Waisfisz Q; Friesema EC; Langendonk JG; van der Knaap MS
Neurology; 2016 Sep; 87(12):1258-65. PubMed ID: 27558376
[TBL] [Abstract][Full Text] [Related]
3. Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.
Yasuda M; Gan L; Chen B; Yu C; Zhang J; Gama-Sosa MA; Pollak DD; Berger S; Phillips JD; Edelmann W; Desnick RJ
Hum Mol Genet; 2019 Jun; 28(11):1755-1767. PubMed ID: 30615115
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental disorder in a patient with HMBS and SCN3A variants-A possibly blended phenotype further delineating autosomal recessive HMBS related disease.
M K; M R; J B; A BI; K IP; R W; E O; A ZK; R S; R P
Am J Med Genet A; 2024 Aug; 194(8):e63617. PubMed ID: 38568055
[TBL] [Abstract][Full Text] [Related]
5. Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria.
Berger S; Stattmann M; Cicvaric A; Monje FJ; Coiro P; Hotka M; Ricken G; Hainfellner J; Greber-Platzer S; Yasuda M; Desnick RJ; Pollak DD
Acta Neuropathol Commun; 2020 Mar; 8(1):38. PubMed ID: 32197664
[TBL] [Abstract][Full Text] [Related]
6. A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome.
Yang Y; Chen X; Wu H; Peng H; Sun W; He B; Yuan Z
Mol Med Rep; 2020 Jul; 22(1):516-524. PubMed ID: 32377710
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria.
Chen B; Solis-Villa C; Erwin AL; Balwani M; Nazarenko I; Phillips JD; Desnick RJ; Yasuda M
J Inherit Metab Dis; 2019 Jan; 42(1):186-194. PubMed ID: 30740734
[TBL] [Abstract][Full Text] [Related]
8. Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.
Molina L; Zhu J; Trépo E; Bayard Q; Amaddeo G; ; Blanc JF; Calderaro J; Ma X; Zucman-Rossi J; Letouzé E
J Hepatol; 2022 Oct; 77(4):1038-1046. PubMed ID: 35636578
[TBL] [Abstract][Full Text] [Related]
9. Novel A219P mutation of hydroxymethylbilane synthase identified in a Chinese woman with acute intermittent porphyria and syndrome of inappropriate antidiuretic hormone.
Li Y; Qu H; Wang H; Deng H; Liu Z
Ann Hum Genet; 2015 Jul; 79(4):310-2. PubMed ID: 25787008
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP).
Granata F; Mendez M; Brancaleoni V; Castelbon FJ; Graziadei G; Ventura P; Di Pierro E
Mol Genet Metab; 2018 Nov; 125(3):295-301. PubMed ID: 30201327
[TBL] [Abstract][Full Text] [Related]
11. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
[TBL] [Abstract][Full Text] [Related]
12. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
[TBL] [Abstract][Full Text] [Related]
13. HMBS gene mutations and hydroxymethylbilane synthase activity in acute intermittent porphyria: A systematic review.
Li S; Lei JJ; Dong BX; Ren Y; Yang J
Medicine (Baltimore); 2023 Sep; 102(39):e35144. PubMed ID: 37773850
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic study of acute intermittent porphyria in Russia: HMBS gene mutation spectrum and problem of penetrance.
Goncharova M; Pshenichnikova O; Luchinina Y; Pustovoit Y; Karpova I; Surin V
Clin Genet; 2019 Jul; 96(1):91-97. PubMed ID: 31044425
[TBL] [Abstract][Full Text] [Related]
15. Two Novel Hydroxymethylbilane Synthase Splicing Mutations Predispose to Acute Intermittent Porphyria.
Zhang Y; Xiao H; Xiong Q; Wu C; Li P
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681668
[TBL] [Abstract][Full Text] [Related]
16. Identification and molecular analysis of 17 novel variants of hydroxymethylbilane synthase in Chinese patients with acute intermittent porphyria.
Hu Y; Li W; Kang N; Ma L; Teng Q; Mo G; Wu J; Wang X; Bi R; Zhang S
Clin Genet; 2022 Jan; 101(1):116-121. PubMed ID: 34523126
[TBL] [Abstract][Full Text] [Related]
17. New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria.
Gross U; Puy H; Doss M; Robreau AM; Nordmann Y; Doss MO; Deybach JC
Mol Cell Probes; 1999 Dec; 13(6):443-7. PubMed ID: 10657149
[TBL] [Abstract][Full Text] [Related]
18. Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria.
Guillén-Navarro E; Carbonell P; Glover G; Sánchez-Solís M; Fernández-Barreiro A
Ann Hum Genet; 2004 Sep; 68(Pt 5):509-14. PubMed ID: 15469427
[TBL] [Abstract][Full Text] [Related]
19. Acute Intermittent Porphyria: Complete Phenotype in a Patient with p.Arg173Trp Variant in Thailand.
Sriprakoon V; Ittagornpunth C; Puapaiboon N; Bunyahathaipat A; Piriyanon P; Khositseth S; Rojnueangnit K
Am J Case Rep; 2022 Nov; 23():e937695. PubMed ID: 36329616
[TBL] [Abstract][Full Text] [Related]
20. Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation.
van Loggerenberg W; Sowlati-Hashjin S; Weile J; Hamilton R; Chawla A; Sheykhkarimli D; Gebbia M; Kishore N; Frésard L; Mustajoki S; Pischik E; Di Pierro E; Barbaro M; Floderus Y; Schmitt C; Gouya L; Colavin A; Nussbaum R; Friesema ECH; Kauppinen R; To-Figueras J; Aarsand AK; Desnick RJ; Garton M; Roth FP
Am J Hum Genet; 2023 Oct; 110(10):1769-1786. PubMed ID: 37729906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
